Evaxion Biotech A/S Total Liabilities

Evaxion Biotech A/S (EVAX) currently reports a total liabilities of $10M as of March 2026. That compares with $15M in the prior-year period — down 30.1% year over year. Use the charts on this page to explore Evaxion Biotech A/S's total liabilities history and peer comparisons.

Evaxion Biotech A/S's total liabilities decreased from $15M to $10M — a 30.1% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Evaxion Biotech A/S reported $10M in total liabilities as of March 2026. That compares with $15M in the prior-year period — down 30.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $10M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Evaxion Biotech A/S, and consider following EVAX for alerts when major investors trade the stock.

Evaxion Biotech A/S is classified in the Healthcare sector. On total liabilities, it currently shows $10M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EVAX with unrelated industries.